Schedule 13G ownership disclosure
AUTOLUS THERAPEUTICS LTD
American Depositary Shares, each representing one ordinary share, par value $0.000042 per share · CUSIP: 05280R100
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Armistice Capital, LLC
Shares: 15,600,000.00 · Class: 5.86%
- Steven Boyd
Shares: 15,600,000.00 · Class: 5.86%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-25-005172
- Form type
- SCHEDULE 13G
- Filer
- ARMISTICE CAPITAL, LLC
- CIK
- CIK 1601086
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership